Tango Therapeutics (TNGX) Revenue (QoQ) (2020 - 2025)
Tango Therapeutics (TNGX) Revenue (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Tango Therapeutics | 3.93 Bn | 3.77 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,591.64% |
| Jun 30, 2025 | -41.01% |
| Mar 31, 2025 | 30.97% |
| Dec 31, 2024 | -64.53% |
| Sep 30, 2024 | -41.60% |
| Jun 30, 2024 | 207.14% |
| Mar 31, 2024 | 19.15% |
| Dec 31, 2023 | -49.39% |
| Sep 30, 2023 | -26.48% |
| Jun 30, 2023 | 153.17% |
| Mar 31, 2023 | -10.06% |
| Dec 31, 2022 | -7.36% |
| Sep 30, 2022 | 19.91% |
| Jun 30, 2022 | 0.23% |
| Mar 31, 2022 | 0.73% |
| Dec 31, 2021 | -15.78% |
| Sep 30, 2021 | -62.61% |
| Jun 30, 2021 | 184.26% |
| Mar 31, 2021 | 3.50% |
| Dec 31, 2020 | -45.21% |